Skip to main content
/
Immunocore Holdings plc (IMCR)
NASDAQ: IMCR · Real-Time Price · USD
32.36
-0.55 (-1.67%)
At close: Jun 17, 2025, 4:00 PM
31.59
-0.77 (-2.38%)
After-hours: Jun 17, 2025, 4:35 PM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
 FY 2024FY 2023FY 2022FY 2021FY 2020 2018 - 2019
Period Ending
 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
Immunotherapies
310.20M
Log In
Log In
Log In
Log In
Upgrade
Immunotherapies Growth
24.37%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
 FY 2024FY 2023FY 2022FY 2021FY 2020 2018 - 2019
Period Ending
 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
United States
226.90M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
25.72%
Log In
Log In
Log In
Log In
Upgrade
Europe
73.22M
Log In
Log In
Log In
Log In
Upgrade
Europe Growth
8.27%
Log In
Log In
Log In
Log In
Upgrade
International
10.08M
Log In
Log In
Log In
Log In
Upgrade
International Growth
665.81%
Log In
Log In
Log In
Log In
Upgrade
United Kingdom
-
Log In
Log In
Log In
Log In
Upgrade
United Kingdom Growth
-
Log In
Log In
Log In
Log In
Upgrade